http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5679693-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 |
filingDate | 1996-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8738c61df6b07f77d92ebb909f7409af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18f581a499cfc3b78310496ce95992ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb83d587abbc3f36e192d6f78aee926 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e61480aca97c2a4daea522072aa31f8 |
publicationDate | 1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-5679693-A |
titleOfInvention | 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present |
abstract | The invention relates to quaternary basic amides of the formula <IMAGE> (I) in which Ar is an optionally substituted mono-, di- or tricyclic aromatic or heteroaromatic group; T is a direct bond, a hydroxymethylene group, an alkoxymethylene group in which the alkoxy group is C1-C4, or a C1-C5-alkylene group; Ar' is an unsubstituted or mono- or poly-substituted phenyl, a thienyl, a benzothienyl, a naphthyl or an indolyl; R is hydrogen or a C1-C4-alkyl, or a C1-C4- omega -alkoxy(C2-C4)alkyl, or a C2-C4- omega -alkanoyloxy (C1-C4)alkyl;. Q is hydrogen; or else Q and R together form a 1,2-ethylene, 1,3-propylene or 1,4-butylene group; Am(+) is the radical <IMAGE> in which X1, X2 and X3, together with the nitrogen atom to which they are bonded, form a 1-AZONIABICYCLO[2.2.1]HEPTANE optionally substituted by a phenyl or benzyl group; and A(-) is a pharmaceutically acceptable anion. These compounds are useful for the preparation of drugs intended for the treatment of pathological conditions involving the tachykinin system. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6602886-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135434-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7560549-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017376363-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6303626-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040316-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447485-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010078258-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018108089-A1 |
priorityDate | 1992-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 801.